Baird Medical Investment Holdings Limited (BDMD) vs SCYNEXIS, Inc. (SCYX)
A side-by-side comparison of Baird Medical Investment Holdings Limited and SCYNEXIS, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDMD
Baird Medical Investment Holdings Limited
$0.73HealthcareDelayed quote: Oct 6, 2026, 1:44 PM EDT
SCYX
SCYNEXIS, Inc.
$4.89HealthcareDelayed quote: Oct 6, 2026, 1:46 PM EDT
Total return — BDMD vs SCYX
growth of $100 · dividends reinvested · last 5yBDMD -92.3% (-40.1%/yr)SCYX -91.1% (-38.4%/yr)SCYX compounded faster over this window
BDMD SCYX
BDMD vs SCYX: by the numbers
- •BDMD is the larger company ($31M vs $31M market cap).
- •Both run net losses; SCYX's is the smaller (-53.27% vs -121.04% net margin).
- •SCYX grew revenue faster over the past five years (9.78% vs 4.46% CAGR).
Metrics side by side
Valuation
| Metric | BDMD | SCYX |
|---|---|---|
| Forward P/E | 9.14 | N/A |
| P/S ratio | N/A | 1.60 |
| P/B ratio | 0.89 | 0.46 |
Profitability
| Metric | BDMD | SCYX |
|---|---|---|
| Gross margin | 83.79% | 100.00% |
| Operating margin | -113.31% | -78.03% |
| Net margin | -121.04% | -53.27% |
| ROE | -86.96% | -15.29% |
| ROIC | -50.66% | -32.68% |
Growth (annualized)
| Metric | BDMD | SCYX |
|---|---|---|
| Revenue CAGR (5Y) | 4.46% | 9.78% |
| Total return CAGR (5Y) | N/A | -34.13% |
Frequently asked
- Which has grown faster, BDMD or SCYX?
- Over the past five years, SCYX grew revenue faster — BDMD at a 4.46% CAGR versus SCYX at 9.78%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.